🇺🇸 Best Available Treatment in United States

Best Available Treatment (best-available-treatment) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Pricing & reimbursement

Best Available Treatment in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Cardiovascular approved in United States

Frequently asked questions

Is Best Available Treatment approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Best Available Treatment in United States?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.

What does Best Available Treatment cost in United States?

annual_list: USD 13980.00 per year. Final patient cost depends on reimbursement and any patient access scheme.